<110>    OATC Inc.

<120>    Pharmaceutical composition for preventing or treating neuropathic
         pain comprising gene encoding interleukin-4

<130>    OPP20223168KR

<150>    10-2021-0084762
<151>    2021-06-29

<150>    10-2021-0192935
<151>    2021-12-30

<160>    22

<170>    koPatentIn 3.0

<210>    1
<211>    37
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-4 primer with restriction site sequence of EcoRI


<400>    1
gaattctgag ccaccatggg tctcaacccc cagctag                 37


<210>    2
<211>    28
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-4 primer with restriction site sequence of SalI


<400>    2
gtcgacctac gagtaatcca tttgcatg                          28


<210>    3
<211>    29
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-10 primer with restriction site sequence of XbaI


<400>    3
tctagaatgc ctggctcagc actgctatg                           29


<210>    4
<211>    28
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-10 primer with restriction site sequence of SalI


<400>    4
gtcgactcag ctcttcatct tgatcatc                   28


<210>    5
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    TNF-a forward


<400>    5
agcaaaccac caagtggagg a                                21


<210>    6
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    TNF-a reverse


<400>    6
gctggcacca ctagttggtt g                          21


<210>    7
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-6 forward


<400>    7
ccacgatttc ccagagaaca t                    21


<210>    8
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-6 reverse


<400>    8
tccatccagt tgccttcttg g                            21


<210>    9
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    GAPDH forward


<400>    9
aggtcatccc agagctgaac g                             21


<210>    10
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    GAPDH reverse


<400>    10
caccctgttg ctgtagccgt a                          21


<210>    11
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-4 forward


<400>    11
cctcacagca acgaagaaca                            20


<210>    12
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-4 reverse


<400>    12
atcgaaaagc ccgaaagagt                               20


<210>    13
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-10 forward


<400>    13
tgaattccct gggtgagaag                                       20


<210>    14
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    IL-10 reverse


<400>    14
tggccttgta gacaccttgg                                     20


<210>    15
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Arg-1 froward


<400>    15
tcacctgagc tttgatgtcg                                  20


<210>    16
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Arg-1 reverse


<400>    16
ttcccaagag ttgggttcac                           20


<210>    17
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Ym-1 froward


<400>    17
actttgatgg cctcaacctg                          20


<210>    18
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Ym-1 reverse


<400>    18
aatgattcct gctcctgtgg                              20


<210>    19
<211>    462
<212>    DNA
<213>    Homo sapiens

<400>    19
atgggtctca cctcccaact gcttccccct ctgttcttcc tgctagcatg tgccggcaac         60

tttgtccacg gacacaagtg cgatatcacc ttacaggaga tcatcaaaac tttgaacagc        120

ctcacagagc agaagactct gtgcaccgag ttgaccgtaa cagacatctt tgctgcctcc        180

aagaacacaa ctgagaagga aaccttctgc agggctgcga ctgtgctccg gcagttctac        240

agccaccatg agaaggacac tcgctgcctg ggtgcgactg cacagcagtt ccacaggcac        300

aagcagctga tccgattcct gaaacggctc gacaggaacc tctggggcct ggcgggcttg        360

aattcctgtc ctgtgaagga agccaaccag agtacgttgg aaaacttctt ggaaaggcta        420

aagacgatca tgagagagaa atattcaaag tgttcgagct ga                           462


<210>    20
<211>    411
<212>    DNA
<213>    Homo sapiens

<400>    20
atgggtctca cctcccaact gcttccccct ctgttcttcc tgctagcatg tgccggcaac         60

tttgtccacg gacacaagtg cgatatcacc ttacaggaga tcatcaaaac tttgaacagc        120

ctcacagagc agaagactct gtgcaccgag ttgaccgtaa cagacatctt tgctgcctcc        180

aagcagcatg catgtctgcc cacctccaga cacacaggca ccatctgccg ccccccatca        240

gcccgtgtcc cttccacctc gactcgccta caaagcccag agagaacaca actgagaagg        300

aaaccttctg cagggctgcg actgtgctcc ggcagttcta cagccaccat gagaaggaca        360

ctcgctgcct gggtgcgact gcacagcagt tccacaggca caagcagctg a                 411


<210>    21
<211>    153
<212>    PRT
<213>    Homo sapiens

<400>    21
Met Gly Leu Thr Ser Gln Leu Leu Pro Pro Leu Phe Phe Leu Leu Ala
  1               5                  10                  15 

Cys Ala Gly Asn Phe Val His Gly His Lys Cys Asp Ile Thr Leu Gln
             20                  25                  30 

Glu Ile Ile Lys Thr Leu Asn Ser Leu Thr Glu Gln Lys Thr Leu Cys
         35                  40                  45 

Thr Glu Leu Thr Val Thr Asp Ile Phe Ala Ala Ser Lys Asn Thr Thr
     50                  55                  60 

Glu Lys Glu Thr Phe Cys Arg Ala Ala Thr Val Leu Arg Gln Phe Tyr
 65                  70                  75                  80 

Ser His His Glu Lys Asp Thr Arg Cys Leu Gly Ala Thr Ala Gln Gln
                 85                  90                  95 

Phe His Arg His Lys Gln Leu Ile Arg Phe Leu Lys Arg Leu Asp Arg
            100                 105                 110 

Asn Leu Trp Gly Leu Ala Gly Leu Asn Ser Cys Pro Val Lys Glu Ala
        115                 120                 125 

Asn Gln Ser Thr Leu Glu Asn Phe Leu Glu Arg Leu Lys Thr Ile Met
    130                 135                 140 

Arg Glu Lys Tyr Ser Lys Cys Ser Ser
145                 150            


<210>    22
<211>    136
<212>    PRT
<213>    Homo sapiens

<400>    22
Met Gly Leu Thr Ser Gln Leu Leu Pro Pro Leu Phe Phe Leu Leu Ala
  1               5                  10                  15 

Cys Ala Gly Asn Phe Val His Gly His Lys Cys Asp Ile Thr Leu Gln
             20                  25                  30 

Glu Ile Ile Lys Thr Leu Asn Ser Leu Thr Glu Gln Lys Thr Leu Cys
         35                  40                  45 

Thr Glu Leu Thr Val Thr Asp Ile Phe Ala Ala Ser Lys Gln His Ala
     50                  55                  60 

Cys Leu Pro Thr Ser Arg His Thr Gly Thr Ile Cys Arg Pro Pro Ser
 65                  70                  75                  80 

Ala Arg Val Pro Ser Thr Ser Thr Arg Leu Gln Ser Pro Glu Arg Thr
                 85                  90                  95 

Gln Leu Arg Arg Lys Pro Ser Ala Gly Leu Arg Leu Cys Ser Gly Ser
            100                 105                 110 

Ser Thr Ala Thr Met Arg Arg Thr Leu Ala Ala Trp Val Arg Leu His
        115                 120                 125 

Ser Ser Ser Thr Gly Thr Ser Ser
    130                 135    
